7 years ago

CMR Surgical Raises $100 Million to Commercialize Surgical Robot

  • CMR Surgical, a Cambridge, UK-based company developing a next-generation surgical robot, has secured $100 million in Series B funding

  • The round was led by Zhejiang Silk Road Fund, with participation from existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital, and Watrium

  • CMR Surgical plans to use the funds to prepare its Versius® system for commercialization, including completing validation studies for regulatory approval, expanding internationally, and scaling up commercial operations

  • Versius® is a universal robotic system designed for minimal access surgery across various specialties, and CMR Surgical is currently conducting preclinical trials to demonstrate its capabilities in upper gastrointestinal, gynecological, colorectal, and renal surgery.

      • ProblemHealthcare

      "streamlining the surgical process to make minimally invasive surgeries more efficient and accessible"

      Solution

      "a universal robotic system called Versius that can perform various types of minimal access surgery"

      Covered on